Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nano-X Imaging (NNOX) EPS (Weighted Average and Diluted) (2022 - 2025)

Nano-X Imaging posted quarterly EPS (Weighted Average and Diluted) of -$567.39 for Q4 2025, down 133.63% year-on-year from $1687.0 in Q4 2024, and down 133.63% on a QoQ basis from -$242.85 in Q4 2024.

Nano-X Imaging (NNOX) has 4 years of EPS (Weighted Average and Diluted) data on file, last reported at -$567.39 in Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 133.63% year-over-year to -$567.39; the trailing twelve-month figure through Dec 2025 stood at -$567.39 (down 133.63% YoY), and the FY2025 full-year result was -$1.16, down 27.47% from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 stood at -$567.39, down from -$242.85 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$1.05 in Q4 2022 and bottomed at -$567.39 in Q4 2025.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$213.73 (2023), against an average of -$248.98.
  • The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) slumped 17464.37%; it then sank 31.55% in 2024.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.05 in 2022, then plunged by 17464.37% to -$184.61 in 2023, then tumbled by 31.55% to -$242.85 in 2024, then plunged by 133.63% to -$567.39 in 2025.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$567.39 (Q4 2025), -$242.85 (Q4 2024), and -$184.61 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Nano-X Imaging 126,664.45 -59.48 Mn -3.62 Mn -567.39

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -567.39
Dec 31, 2024 -242.85
Dec 31, 2023 -184.61
Dec 31, 2022 -1.05